Envista Obtains FDA Clearance for Assisted Intelligence Nerve Tracing
Envista Holdings Corporation (NYSE: NVST) (“Envista”) — Envista announced today the 510(k) Food and Drug Administration (FDA) clearance of its Assisted Intelligence (AI) mandibular nerve tracing...
